INVO Bioscience Inc

NASDAQ:INVO   2:05:14 PM EDT
0.99
-0.03 (-2.97%)
Earnings Announcements

INVO Bioscience Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:46 GMT
INVO Bioscience Inc (INVO) - Invo Bioscience Reports Third Quarter 2022 Financial Results.
Invo Bioscience Inc- Qtrly Loss per Share $0.21.
Revenue is expected to be $0.3 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $2.37 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.